Abbvie to become the biggest of pharmas in 2028

Despite facing one of the steepest patent cliffs in the industry’s history Abbvie is expected to rise up the rankings ahead of Roche to become the biggest pharma company by prescription sales in 2028, according to extended consensus forecasts from Evaluate Pharma.

Abbvie’s gain contrasts with the slide down the rankings by Pfizer, Novartis and Bristol Myers Squibb, the last of which is facing significant patent erosion of its own. Three of Bristol's blockbusters – Revlimid, Eliquis and Opdivo – could see cheaper copycats arrive over the next six years.